To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Condition(s):T2DM (Type 2 Diabetes Mellitus); DyslipidemiasLast Updated:March 7, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):T2DM (Type 2 Diabetes Mellitus); DyslipidemiasLast Updated:March 7, 2024Not yet recruiting
Condition(s):EfficacyLast Updated:February 1, 2024Not yet recruiting
Condition(s):Atrial Fibrillation; Anticoagulant Adverse ReactionLast Updated:January 5, 2024Recruiting
Condition(s):Microvascular AnginaLast Updated:October 13, 2023Recruiting
Condition(s):EfficacyLast Updated:August 15, 2023Active, not recruiting
Condition(s):Diabetes Mellitus, Type 2; DepressionLast Updated:August 18, 2023Completed
Condition(s):Recurrent or Metastatic Colorectal CancerLast Updated:August 14, 2023Not yet recruiting
Condition(s):Dyslipidemias; Stroke, Acute IschemicLast Updated:June 1, 2023Recruiting
Condition(s):Diabetes Mellitus; Coronary Artery DiseaseLast Updated:March 13, 2023Recruiting
Condition(s):Colonic NeoplasmsLast Updated:March 7, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.